Literature DB >> 15218485

Nitric oxide and arterial disease.

Joel E Barbato1, Edith Tzeng.   

Abstract

Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218485     DOI: 10.1016/j.jvs.2004.03.043

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  33 in total

1.  Mechanical properties and biocompatibility of plasma-nitrided laser-cut 316L cardiovascular stents.

Authors:  Erdem Arslan; Mustafa C Iğdil; Hilal Yazici; Candan Tamerler; Hakan Bermek; Levent Trabzon
Journal:  J Mater Sci Mater Med       Date:  2007-10-30       Impact factor: 3.896

Review 2.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

3.  Mediterranean diet, physical activity and subcutaneous advanced glycation end-products' accumulation: a cross-sectional analysis in the ILERVAS project.

Authors:  Enric Sánchez; Àngels Betriu; Jordi Salas-Salvadó; Reinald Pamplona; Ferrán Barbé; Francesc Purroy; Cristina Farràs; Elvira Fernández; Carolina López-Cano; Chadia Mizab; Albert Lecube
Journal:  Eur J Nutr       Date:  2019-05-07       Impact factor: 5.614

4.  Functional characterization of human pluripotent stem cell-derived arterial endothelial cells.

Authors:  Jue Zhang; Li-Fang Chu; Zhonggang Hou; Michael P Schwartz; Timothy Hacker; Vernella Vickerman; Scott Swanson; Ning Leng; Bao Kim Nguyen; Angela Elwell; Jennifer Bolin; Matthew E Brown; Ron Stewart; William J Burlingham; William L Murphy; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

5.  Comparison of in vitro human endothelial cell response to self-expanding stent deployment in a straight and curved peripheral artery simulator.

Authors:  Ríona Ní Ghriallais; Laoise McNamara; Mark Bruzzi
Journal:  J R Soc Interface       Date:  2013-01-30       Impact factor: 4.118

Review 6.  Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?

Authors:  Andrea Tryfonos; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

7.  Long-term pleiotropic effect of statins upon nitric oxide and C-reactive protein levels in patients with peripheral arterial disease.

Authors:  S Bleda; J De Haro; A Florez; C Varela; L Esparza; F Acin
Journal:  Heart Asia       Date:  2011-01-01

8.  Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Omar L Esponda; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2013-09-03       Impact factor: 3.619

9.  Stabilization and characterization of a heme-oxy reaction intermediate in inducible nitric-oxide synthase.

Authors:  Jesús Tejero; Ashis Biswas; Zhi-Qiang Wang; Richard C Page; Mohammad Mahfuzul Haque; Craig Hemann; Jay L Zweier; Saurav Misra; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

10.  Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.

Authors:  Luis A Brito; Saradha Chandrasekhar; Steven R Little; Mansoor M Amiji
Journal:  Biomed Eng Online       Date:  2010-09-27       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.